Corgenix to Exhibit AspirinWorks(R) Test at 2008 ACOFP Meeting...( DENVER March 7 /- Corgenix Medica...),Health

DENVER, March 7 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, will be exhibiting its AspirinWorks(R) Test at the American College of Family Physicians 45th Annual Convention & Exhibition. ACOFP 2008 conference is being held March 12-14 at the Colorado Convention Center in Denver.

Corgenix representatives will be on-hand at booth #807 during ACOFP to answer questions about the AspirinWorks test, including its availability, the latest supporting clinical data and ordering information.

AspirinWorks is a simple urine test that determines the effect of aspirin on platelets by measuring the level of thromboxane production (aspirin's target). The higher the levels of thromboxane, the stickier the blood platelets, and the less impact the aspirin is having. This crucial information allows physicians to individualize a patient's therapy.

Unlike other platelet tests, which require freshly drawn blood that must be evaluated within four hours, the AspirinWorks test only requires a urine sample that can be obtained in any doctor's office or patient service center, making the test easy for both physician and patient.

"The ACOFP conference represents a special opportunity to reach this medical specialty," said Corgenix' Clinical Affairs Director Gordon Ens. "With their awareness of the differences among individual patients, we're confident attendees will appreciate the ability to identify individual response to aspirin."

The AspirinWorks Test, which was launched in the United States in June 2007 following FDA 510(k) clearance, is now available nationwide through major medical reference laboratories, as well as direct to consumers through HealthCheckUSA (http://www.HealthCheckUSA.com).

The AspirinWorks Test Kit is an enzyme-linked immunoassay (ELISA) to determine levels of 11 Dehydr
'/>"/>